Ozempic Hype Forces Employer Calls on Obesity Coverage
Employers are facing a big dilemma: How do they pay for the new highly effective and popular obesity medications without breaking the bank?
Read MoreEmployers are facing a big dilemma: How do they pay for the new highly effective and popular obesity medications without breaking the bank?
Read MoreA large randomized trial showed home visits from nurses for pregnant people did not improve their or their babies’ health outcomes.
Read MoreA recent JAMA study sheds light on how the manufacturers of a class of popular weight-loss drugs have avoided competition from more affordable generics.
Read MoreA new study suggests doctors struggle to know when and how to act on heart rhythm data generated by patients’ smartwatches.
Read MoreExperts from the Tradeoffs Advisory Board share some of their favorite new health policy studies.
Read MoreRecent analyses in JAMA and by the Kaiser Family Foundation raise questions about whether Medicare and its beneficiaries can afford a new wave of Alzheimer’s treatments.
Read MoreNew guidelines for clinicians suggest there’s not enough evidence to screen most adults for suicide risk.
Read MoreA study in JAMA Internal Medicine calculates the cost of fully meeting the social needs of primary care patients – and finds the current system falls short.
Read MoreA recent NBER working paper looks at the effects of immigration into the U.S. on the staffing and quality of nursing homes.
Read More